CD8A and neoplasm: Vitamin C could improve tumor cytotoxicity of adoptively transferred CD8+ T lymphocytes and potentiate clinical efficacy of ICT with anti-PD-1 and anti-CTLA-4 monoclonal antibodies in a breast murine model.